P4 Preclinical evaluation of an mRNA-based therapeutic HIV vaccine candidate combining rationally selected antigenic sequences and potent adjuvant signals (HTI-TriMix)

• P. Tjok Joe,
• A.C. Guardo,
• L. Miralles,
• M.E. Bargalló,
• M.J. Maleno,
• B. Mothe,
• A. Krasniqi,
• C. Heirman,
• F. García,
• J.M. Gatell,
• K. Thielemans,
• C. Brander,
• M. Plana,
• J.L. Aerts

Affiliations

P. Tjok Joe

Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels Belgium

A.C. Guardo

IDIBAPS, Barcelona, Spain

L. Miralles

IDIBAPS, Barcelona, Spain

M.E. Bargalló

IDIBAPS, Barcelona, Spain

M.J. Maleno

IDIBAPS, Barcelona, Spain

B. Mothe

IrsiCaixa HIVACAT, Autonomous University of Barcelona, Hospital Germans Trias i Pujol, Badalona, Spain

A. Krasniqi

Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels Belgium

C. Heirman

Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels Belgium

F. García

Infectious Diseases Department, Hospital Clinic de Barcelona, Barcelona, Spain

J.M. Gatell

Infectious Diseases Department, Hospital Clinic de Barcelona, Barcelona, Spain

K. Thielemans

Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels Belgium

C. Brander

IrsiCaixa HIVACAT, Autonomous University of Barcelona, Hospital Germans Trias i Pujol, Badalona, Spain

M. Plana

IDIBAPS, Barcelona, Spain

J.L. Aerts

Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels Belgium